Artivion Inc
Research Artivion Inc (AORT) on Bullrun: market cap USD 1.28B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAORT
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 1.28B
- Financial periodQ2 2026
- RevenueUSD 125.76M
- Net income-USD 13.51M
- Free cash flow-USD 12.01M
- Gross margin64.0%
Valuation Snapshot
latest market cap is USD 1.28B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 441.33M | USD 9.77M | USD 839.00K | 64.4% | 0.21 | USD 64.91M | USD 215.11M | USD 448.23M |
| FY2024 | USD 388.54M | -USD 13.36M | USD 11.05M | 64.0% | -0.32 | USD 53.46M | USD 314.35M | USD 276.20M |
| FY2023 | USD 354.00M | -USD 30.69M | USD 9.07M | 64.7% | -0.75 | USD 58.94M | USD 306.98M | USD 281.78M |
| FY2022 | USD 313.79M | -USD 19.19M | -USD 15.87M | 64.5% | -0.48 | USD 39.35M | USD 308.11M | USD 284.33M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.28B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.18B | 228.0 | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.20B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 733.95M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 488.79M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 812.17M | n/a | n/a | n/a |
About Artivion Inc
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Artivion Inc's market cap?
Artivion Inc's market capitalization is USD 1.28B.
What does Artivion Inc do?
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system.